EvoBiotech Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

EvoBiotech General Information

Description

Developer of a biotechnology platform designed to connect scientific research with patient and healthcare professional needs in wound care and drug delivery. The company offers plant-derived extracellular vesicle technology with defined biological properties, enabling the healthcare industry to improve therapy performance and support alternative delivery methods.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Piazza Statuto 18
  • 10122 Turin
  • Italy
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • Piazza Statuto 18
  • 10122 Turin
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EvoBiotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 02-Feb-2026 Completed Out of Business
3. Secondary Transaction - Private Completed Generating Revenue
2. Accelerator/Incubator 23-Oct-2023 $1.22M Completed Generating Revenue
1. Seed Round 08-Jun-2021 $1.22M $1.22M Completed Startup
To view EvoBiotech’s complete valuation and funding history, request access »

EvoBiotech Patents

EvoBiotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3208317-A1 Composition comprising engineered plant-derived extracellular vesicles and use thereof as a vaccine Active 14-Jan-2021
WO-2022152771-A1 Composition comprising engineered plant-derived extracellular vesicles and use thereof as a vaccine Inactive 14-Jan-2021
JP-2024508357-A Compositions containing genetically engineered, plant-derived extracellular vesicles and their use as vaccines Active 14-Jan-2021
JP-2023540610-A Pharmaceutical composition in hydrogel form containing extracellular vesicles derived from orange Pending 10-Sep-2020
CA-3194809-A1 Pharmaceutical composition in the form of a hydrogel comprising orange-derived extracellular vesicles Pending 10-Sep-2020 A61K9/0014
To view EvoBiotech’s complete patent history, request access »

EvoBiotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EvoBiotech FAQs

  • When was EvoBiotech founded?

    EvoBiotech was founded in 2019.

  • Where is EvoBiotech headquartered?

    EvoBiotech is headquartered in Turin, Italy.

  • What is the size of EvoBiotech?

    EvoBiotech has 2 total employees.

  • What industry is EvoBiotech in?

    EvoBiotech’s primary industry is Biotechnology.

  • Is EvoBiotech a private or public company?

    EvoBiotech is a Private company.

  • What is EvoBiotech’s current revenue?

    The current revenue for EvoBiotech is .

  • How much funding has EvoBiotech raised over time?

    EvoBiotech has raised $1.22M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process